KIERAN T. GALLAHUE

Former Chairman & CEO of Carefusion from 2011 until its sale to Becton Dickinson for over $12bn in 2015.

Former CEO and director of Resmed from 2008 to 2011, President 2003-2007.

Former President of Nanogen Genetics from 2000 to 2002.

Has served on numerous public and private company boards including Edwards Lifesciences, Envista Co., Intersect ENT, Arena Pharmaceuticals, Volcano Corporation, Signifier Medical Technologies, and Nucleus Biologics.